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The most deadly of the human malaria parasites, Plasmodium falciparum, has different stages special-
ized for invasion of hepatocytes, erythrocytes, and the mosquito gut wall. In each case, host cell invasion
is powered by an actin-myosin motor complex that is linked to an inner membrane complex (IMC) via a
membrane anchor called the glideosome-associated protein 50 (PfGAP50). We generated P. falciparum
transfectants expressing green fluorescent protein (GFP) chimeras of PfGAP50 (PfGAP50-GFP). Using
immunoprecipitation and fluorescence photobleaching, we show that C-terminally tagged PfGAP50-GFP
can form a complex with endogenous copies of the linker protein PfGAP45 and the myosin A tail
domain-interacting protein (MTIP). Full-length PfGAP50-GFP is located in the endoplasmic reticulum in
early-stage parasites and then redistributes to apical caps during the formation of daughter merozoites.
In the final stage of schizogony, the PfGAP50-GFP profile extends further around the merozoite surface.
Three-dimensional (3D) structured illumination microscopy reveals the early-stage IMC as a doubly
punctured flat ellipsoid that separates to form claw-shaped apposed structures. A GFP fusion of PfGAP50
lacking the C-terminal membrane anchor is misdirected to the parasitophorous vacuole. Replacement of
the acid phosphatase homology domain of PfGAP50 with GFP appears to allow correct trafficking of the
chimera but confers a growth disadvantage.
Despite intense efforts to roll back malaria, it remains one of
the most devastating diseases of modern times, with close to 1
million deaths recorded annually (42). Plasmodium falciparum
is the human malaria species that is responsible for most of the
malaria-associated mortality and morbidity. Upon transmis-
sion to a human, the parasite undergoes one round of multi-
plication in the liver prior to initiating the symptomatic asexual
blood phase of malaria infection.
The intraerythrocytic cycle commences when a merozoite
invades a red blood cell (RBC). The merozoite attaches to
ligands on the RBC surface and then reorients so that its apical
end can form a tight junction with the RBC membrane (17, 31,
38). Once this junction is established, the parasite uses gliding
motility to enter the host cell, forming the parasitophorous
vacuole (PV) and PV membrane as it invades (16, 30, 39). The
gliding motion is driven by an actin-myosin motor present
within the pellicle of the invading merozoite (27).
The pellicle structure is a flattened double-membrane-
bound cisterna that subtends the parasite plasma membrane
and is known as the inner membrane complex (IMC). Actin
filaments, which are thought to lie between the plasma mem-
brane and the IMC (7, 33), are connected via aldolase to an
adhesin, which in the asexual blood stages is the merozoite
thrombospondin-related adhesive protein (mTRAP). mTRAP
is a type I integral membrane protein with a short cytoplasmic
tail and an adhesive extracellular domain that may bind to the
RBC or to another invasion protein (8). The actin filaments
connect to myosin A (myoA) heavy chain (33), which in turn is
anchored to the IMC via a light chain or myosin A tail domain-
interacting protein (MTIP) (10). Two further IMC proteins,
the peripheral protein P. falciparum glideosome-associated
protein 45 (PfGAP45) and the transmembrane protein
PfGAP50, form a complex with myoA and MTIP and together
make up what has been called the glideosome, or motor com-
plex (7, 27). Originally described in the related apicomplexan
parasite Toxoplasma gondii (20), the components of the motor
complex have more recently been characterized in P. falcipa-
rum (9, 22, 26).
The IMC is critical for merozoite motility and viability, but
little is known of its origins or of the pathways for trafficking
proteins to the organelle. In this work, we use transgenic par-
asites expressing green fluorescent protein (GFP) fusion con-
structs of the IMC-resident protein PfGAP50 (PfGAP50-GFP)
to study the genesis of the IMC during parasite development.
We use live-cell confocal and three-dimensional structured
illumination microscopy (3D-SIM) to dissect the amino acid
sequence requirements for PfGAP50 trafficking, as well as the
timing and order of IMC reorganization during asexual devel-
opment and merozoite formation.
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MATERIALS AND METHODS
Parasite culture, transfection, and PfGAP50-GFP constructs. P. falciparum
parasites (strain 3D7) were maintained in O-type human RBCs from the Mel-
bourne Red Cross Blood Bank in RPMI-HEPES medium supplemented with
5% human serum and 0.5% Albumax (19). Tight synchronization of cultures was
achieved using a modification of the method previously described (34). Briefly,
schizont stage parasites were purified using 70% (wt/vol) Percoll. Purified par-
asites were immobilized as a monolayer in a dish coated with concanavalin A.
Uninfected RBCs were overlaid for 30 min and then removed to begin a new
culture of highly synchronous parasites. The timing of the synchronous culture
was measured from the beginning of the 30-min incubation period. Aliquots were
taken every hour for confocal microscopic analysis.
PfGAP50 (PlasmoDB gene identifier, PFI0880c) comprises four distinct do-
mains, as shown in Fig. 1A. PfGAP50 is characterized by a hydrophobic N-ter-
minal signal sequence with a predicted cleavage site after amino acid 25, an acid
phosphatase homology domain, a transmembrane domain, and a 5-amino-acid
predicted cytoplasmic domain (SKNMK). The full-length PfGAP50 gene was
PCR amplified using primers 5-TCAGAACTCGAGATGAATTATTGTAAA
ACCACGTTCC-3 and 5-TATGGTACCTTTCATATTTTTTGATAAAAAA
GAGGAAGC-3. A C-terminal PfGAP501-369 was constructed using the above
forward primer and the alternative reverse primer 5-ACCAATGGTACCTAC
AACTCTAACAAAGGTATC-3. The DNA fragments were digested with
XhoI/KpnI (underlined) and cloned into the P. falciparum transfection vector
pGLUX1 (A. G. Maier, M. T. O’Neill, and A. F. Cowman, unpublished data),
which incorporates the human dihydrofolate reductase (hDHFR) cassette for
positive selection with the prodrug WR99210 (18). This vector drives transgene
expression from the PfCRT 5 promoter region, which has maximal expression in
the late ring stages (11). A second mutant, in which the acid phosphatase domain
of PfGAP50 is replaced with GFP (PfGAP50AP-GFP), was constructed using
overlapping PCR. The PfGAP50 N-terminal and C-terminal domains and the
GFP coding sequence were amplified from 3D7 genomic DNA using the follow-
ing primer pairs. N-terminal, 5-GATATGTCAATATTTGTATAACACATGA
AG-3 and 5-TTCTTCTCCTTTACTCCAATCACCCAAAGA-3; C-terminal,
5-GATGAACTATACAAATTTGTTAGAGTTGTA-3 and 5-TAACATTTA
TTCATTATAATATTTATCATATTATATATATA-3; and GFP, 5-AGTAAA
GGAGAAGAACTTTTCACTGGAGTTGTC-3 and 5-TTTGTATAGTTCAT
CCATGCCATGTGTAATCCC-3. The final construct was generated by PCR
using the overlapping product as a template and 5-TCAGAACTCGAGATGA
ATTATTGTAAAACCACGTTCC-3 and 5-GCGCTTAATTAATTATTTCA
TATTTTTTGATAAAA-3. The PCR product was digested with XhoI/PacI
(underlined), purified, and cloned into the pGLUX1 vector. 3D7 parasites were
transfected with 100 g of purified plasmid DNA as previously described (13).
The episomal constructs were maintained by culturing them in the presence of 10
nM WR99210.
Western analysis of PfGAP50-GFP transgenic parasites. Highly synchronized
late-stage PfGAP50-GFP parasites were purified using 70% (wt/vol) Percoll and
treated with streptolysin O (SLO) (1.5 U/l final concentration) at 37°C for 15
min to remove hemoglobin (40). The cells were lysed with 3 rapid freeze-thaw
cycles in phosphate-buffered saline (PBS), and the soluble and insoluble fractions
were separated by centrifugation at 12,000  g for 10 min at 4°C. Proteins were
separated on 4 to 12% SDS NuPage gels (Invitrogen) under reducing conditions
and transferred onto nitrocellulose membranes. The membranes were probed
with either mouse anti-GFP (Roche; 1:500), anti-PfGAP45 (1/500 dilution),
anti-PfGAP50 (1:500) (9) or anti-MTIP (22), or rabbit anti-PfGAPDH (36),
followed by horseradish peroxidase-conjugated sheep anti-mouse or anti-rabbit
secondary antibodies (Promega; 1:5,000). Western blots were developed using
enhanced chemiluminescence.
Immunoprecipitation of IMC components. Highly synchronized late-stage
parasites were purified over 70% (wt/vol) Percoll, and proteins were extracted by
incubating them on ice for 15 min in RIPA buffer (1% octylphenoxypoly-
ethoxyethanol [IGEPAL CA-630], 150 mM NaCl, 0.5% sodium deoxycholate
[DOC], 0.1% sodium dodecyl sulfate [SDS], 50 mM Tris, pH 7.4). Soluble and
insoluble fractions were separated by centrifugation at 12,000  g for 10 min at
4°C. Soluble lysates were incubated for 1 h at 4°C using the rabbit antibodies
anti-PfGAP45, anti-GFP, and anti-MTIP and preimmune serum. A 1:1 ratio of
protein-A/G–Sepharose was used for immunoprecipitation (IP). IP lysates were
separated by SDS-PAGE and analyzed by Western blotting using mouse anti-
bodies against GFP, PfGAP45, or PfMTIP. Western blots were developed as
described above.
Light microscopy and immunofluorescence. For immunofluorescence, air-
dried thin smears were fixed for 10 min at room temperature in 100% acetone,
and antibody labeling was performed as explained below. Alternatively, aliquots
of culture were washed in PBS and fixed for 20 min at room temperature in 2%
paraformaldehyde, 0.008% glutaraldehyde. The cells were permeabilized with
0.1% Triton X-100 for 5 min at room temperature prior to antibody incubation.
The prepared cells were incubated for 1 h with the following antibodies diluted
in 3% bovine serum albumin (BSA) in PBS: mouse anti-GFP (1:500; Roche),
rabbit anti-PfGAP45 (1:500), rabbit anti-PfGAP50 (1:500), rabbit anti-RhopH3
(41) (1:500), and rabbit anti-Bet3 (2) (1:500), followed by Alexa Fluor 488 or 568
anti-IgG (Molecular Probes). Cells were washed in PBS, resuspended in Dako
mounting medium, and viewed using a Leica TCS-SP2 confocal fluorescence
microscope. For labeling of the endoplasmic reticulum (ER) cultures, ER-
Tracker Blue-White DPX (0.25 M; Invitrogen Corporation) was added to an
aliquot of a culture for 30 min at 37°C. The cells were resuspended in fresh
complete medium, and the ER fluorescence pattern was examined using an
Olympus IX81 fluorescence microscope with a DAPI (4,6-diamidino-2-phe-
nylindole) filter set.
For live-cell confocal imaging of transfectants, 3 l of culture (3% hematocrit;
5 to 10% parasitemia) was sealed under a coverslip and viewed on a Leica
TCS-SP2 or a Zeiss LSM 510/FCS confocal microscope within 20 min of mount-
ing. Fluorescence recovery after photobleaching (FRAP) was performed on a
Zeiss LSM 510/FCS, as previously described (28). Selected regions were photo-
bleached using a 488-nm laser at 80% intensity for 0.1 s. Fluorescence images
were acquired before, immediately after, and 3 min after bleaching.
3D-SIM (37) was implemented on a DeltaVision OMX 3D-SIM (optical
microscope, experimental) at the Microbial Imaging Facility of the University of
Technology Sydney. The samples were excited using 405-nm and 488-nm lasers
and imaged using emission filters of 419 to 465 nm and 500 to 550 nm, with a
100 1.4-numerical aperture (NA) oil lens and multichannel simultaneous-
imaging capability (electron-multiplying charge-coupled device cameras; 90%
quantum efficiency; 512 by 512 pixels). Aliquots of culture were adjusted to a
final concentration of 2% paraformaldehyde, 0.008% glutaraldehyde and resus-
FIG. 1. Schematic diagram of the PfGAP50 chimera construct and
Western analysis of PfGAP50-GFP transfectants. (A) The four do-
mains of PfGAP50 are as follows: a predicted signal sequence (SS), an
acid phosphatase homology domain, a predicted transmembrane do-
main (TM), and a short cytoplasmic tail. (B) Late-stage 3D7 parent
and full-length PfGAP50-GFP transfectants were enriched, treated
with streptolysin O, and then lysed by freeze-thaw cycling. Supernatant
(S) and pellet (P) fractions were subjected to Western blotting and
probed with antibodies recognizing PfGAP50 or GFP. The blots
were reprobed with antibodies recognizing the soluble parasite protein
PfGAPDH.
VOL. 10, 2011 VISUALIZING THE P. FALCIPARUM INNER MEMBRANE COMPLEX 557
pended in 50% Vectashield antifade mounting medium (Vectorlabs), containing
DAPI, in PBS. All images were processed using NIH Image J version 1.42
(http://rsbweb.nih.gov/ij/).
Electron microscopy. Transmission electron microscopy (EM) and tomogra-
phy were performed as previously described (14, 23). Briefly, tightly synchronized
early- or late-schizont-stage 3D7 parasites were fixed, embedded, and stained.
Seventy-nanometer-thick sections were observed at 120 keV using a JEOL-
2010HC (Japan) transmission electron microscope (La Trobe University, EM
Unit). For electron tomography, 200- or 300-nm sections were cut, stained, and
observed at 200 keV on a Tecnai G2 F30 (FEI Company) transmission electron
microscope (Bio21 Institute, Melbourne, Australia). Tilt series were collected
and reconstructed to generate cell models as described previously (1).
RESULTS
Full-length PfGAP50-GFP is expressed in transfected P.
falciparum. To examine the genesis and origin of the IMC, P.
falciparum transfectants expressing full-length PfGAP50
tagged at the C terminus with GFP were generated (Fig. 1A).
Mature-stage parasite cultures of the parent (3D7) and trans-
fected (PfGAP50-GFP) lines were harvested and selectively
lysed with streptolysin O to remove the host cell hemoglobin.
The isolated parasites were disrupted by freeze/thawing, and
the supernatant and pellet fractions were subjected to Western
blotting. Anti-PfGAP50 recognizes a band of 42 kDa in the
pellet fraction of 3D7-infected RBCs (Fig. 1B, left), as re-
ported previously (9), and an additional band of 64 kDa in the
PfGAP50-GFP transfectant (Fig. 1B, middle). The relative
intensity of the upper band indicates that PfGAP50-GFP is
expressed at a lower level than endogenous PfGAP50. When
the blotted lysates of the PfGAP50-GFP transfectants were
probed with anti-GFP, only the 64-kDa protein species was
detected (Fig. 1B, right), with no reactivity in 3D7 parasites or
uninfected RBCs (data not shown). The apparent molecular
masses of PfGAP50 and PfGAP50-GFP are in rough agree-
ment with the predicted masses after cleavage of the signal
sequence (41.5 kDa and 68.3 kDa, respectively). The presence
of PfGAP50 and PfGAP50-GFP in the pellet fraction indicates
that they are membrane associated. The blots were stripped
and reprobed with anti-PfGAPDH to compare loading levels
and to validate the lysis procedure (Fig. 1B, bottom).
Full-length PfGAP50-GFP is incorporated into the glideo-
some complex. Endogenous PfGAP50 and PfGAP45 form part
of the glideosome complex that is associated with the IMC (9).
To determine whether full-length PfGAP50-GFP participates
in this complex, we immunoprecipitated IMC components
from the transfectants. Mature-stage parasite-infected RBCs
were enriched and solubilized using a detergent-containing
buffer. Cleared soluble lysates were immunoprecipitated with a
range of antibodies (Fig. 2). When a Western blot of the
precipitated samples was probed with mouse anti-GFP anti-
bodies, a band corresponding to full-length PfGAP50-GFP (64
kDa) was detected in samples precipitated with anti-PfGAP45,
anti-MTIP, and anti-GFP sera, but not with the preimmune
serum (Fig. 2). The lysate sample precipitated using anti-GFP
contained both PfGAP45 and PfMTIP (Fig. 2, right lanes).
Mouse anti-PfGAP45 antiserum detected a doublet at 37 or 39
kDa, while anti-PfMTIP recognized a 27-kDa band. This dem-
onstrates that full-length PfGAP50-GFP is in complex with
endogenous PfGAP45 and PfMTIP.
Live-cell imaging reveals marked rearrangements of the
IMC during parasite development. To follow the movement
and redistribution of PfGAP50 during P. falciparum develop-
ment, we synchronized a parasite culture to within a 2-h win-
dow (34). Confocal microscopy analysis of cells reveals a
marked reorganization of the PfGAP50-GFP as the parasite
matures (Fig. 3; see Fig. S1 in the supplemental material). In
ring and early- to mid-trophozoite stage parasites, PfGAP50-
GFP is present within the parasite in a pattern that is reminis-
cent of that in the ER (Fig. 3; see Fig. S1, top, in the supple-
mental material). In the late-trophozoite/early-schizont stage,
the fluorescence pattern becomes more looped (Fig. 3, 38 to
40 h). At 40 to 42 h postinfection, the PfGAP50-GFP starts to
accumulate into foci, which by 44 h have developed into dis-
tinct puncta at the periphery of the parasite (Fig. 3). The
punctate fluorescent structures are close to bright dots in the
differential interference contrast (DIC) image that probably
represent the rhoptry organelles (see Fig. S1, schizonts, in the
supplemental material). In the final stage of schizogony (46
h postinvasion), the fluorescence appears to redistribute
around the periphery of the daughter merozoites (Fig. 3; see
Fig. S1 in the supplemental material).
Full-length PfGAP50-GFP is trafficked via the ER to apical
regions of developing merozoites. In an effort to determine the
nature of the subcellular compartments with which PfGAP50-
GFP is associated, we undertook colabeling with different
markers. In the early stages of development, ER-Tracker
labels a reticular structure that largely overlaps with the
PfGAP50-GFP location (Fig. 4A, top). The profile is dispersed
and coincident with the pattern for the ER-resident protein
PfERC (ER calcium binding protein) in trophozoite stage par-
asites (Fig. 4B, top).
This is perhaps surprising, given that PfGAP50 has previ-
ously been reported to be a component of the IMC, which lies
under the merozoite plasma membrane. To ensure that this
was not an artifact due to expression of PfGAP50-GFP under
a heterologous promoter, we examined samples of the 3D7
FIG. 2. PfGAP50-GFP interacts with PfGAP45 and PfMTIP.
Proteins were detergent solubilized from enriched, mature-stage
PfGAP50-GFP transfectants. The extract was immunoprecipitated
(IP) using rabbit preimmune serum (Pre), anti-PfGAP45, anti-
PfMTIP, or anti-GFP. Western blots (WB) of the pellet fractions were
probed with mouse anti-GFP, anti-PfGAP45, or anti-PfMTIP. The
antibodies used for IP are shown at the top of the blot, and those for
WB are shown at the bottom.
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parental strain. An antiserum raised against endogenous
PfGAP50 (9) gives a labeling pattern that shows almost com-
plete overlap with that observed for PfGAP50-GFP in both
trophozoite and schizont stage parasites (see Fig. S2A in the
supplemental material). As described above, in schizont stage
parasites, the GFP chimera redistributes to punctate structures
located around the periphery of the dividing parasite (Fig. 4A,
middle). At this stage, ER-Tracker labels reticular structures,
presumably the ER, within the parasite with a diffuse staining
pattern quite unlike that of PfGAP50-GFP. Similarly, in im-
munofluorescence images of schizont stage 3D7 parasites,
PfGAP50 and PfERC are not colocated (Fig. 4B, bottom). The
PfGAP50-containing structures are not Golgi apparatus, as the
labeling patterns for PfGAP50-GFP and the Golgi marker,
PfBet3 (2), are quite distinct (see Fig. S2B in the supplemental
material).
In rupturing schizonts, PfGAP50-GFP is located at the pe-
riphery of individual daughter cells and appears to extend from
one pole, while ER-Tracker labels the inside of individual
merozoites (Fig. 4A, bottom). These data indicate that
PfGAP50-GFP is redistributed from the ER to separate struc-
tures within the dividing cell. Colabeling with the rhoptry
marker RhopH3 (41) confirms the location of PfGAP50-GFP,
extending from the apical region of the daughter merozoites
(see Fig. S2C in the supplemental material).
We compared the location of PfGAP50-GFP in the late
FIG. 3. Dynamics of PfGAP50-GFP-labeled compartments in live
transfectants. Shown is live confocal fluorescence microscopy of highly
synchronized PfGAP50-GFP transfectants. Single section scans (col-
lected at 25 s/pixel) from different cells at 2-h intervals in the schizont
stage are shown (2 cells are represented per time point). At 40 to 42 h
after invasion, reticular structures with looped extensions and focal
concentrations of PfGAP50-GFP are apparent, coalescing into punc-
tate structures by 44 h. The PfGAP50-GFP-containing structures then
appear to expand around each of the daughter merozoites. A more
extended time series is shown in Fig. S1 in the supplemental material.
Bars  1 m.
FIG. 4. PfGAP50 is located in the ER prior to recruitment to the
IMC. (A) Parasites expressing PfGAP50-GFP (green) were incubated
with ER-Tracker (depicted in red). The GFP and ER-Tracker fluo-
rescence signals are colocated in trophozoite stage parasites. Upon
relocation of GFP fluorescence to the apical ends of nascent merozo-
ites during the early schizont stage, the reticular ER-Tracker labeling
persists. PfGAP50-GFP is concentrated at one pole of released mero-
zoites, while ER-Tracker labels internal structures. (B) Fixed-cell im-
munofluorescence microscopy of the 3D7 parent strain labeled with
antibodies raised against PfGAP50 (green) and PfERC (red). (C) Im-
munofluorescence microscopy of PfGAP50-GFP transfectants at the
mature- and ruptured-schizont stages labeled with anti-GFP (green),
anti-PfGAP45 (red), and DAPI (blue). Bars  1 m.
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schizont stage with that of the known IMC-resident protein
PfGAP45 (Fig. 4C, top). In schizont stage parasites, these
proteins appear to be largely colocated in a region of each
daughter merozoite away from the nucleus (i.e., at the apical
end). This is consistent with coparticipation in the IMC. Inter-
estingly, in released merozoites, the locations of PfGAP45 and
PfGAP50-GFP are not completely overlapping (Fig. 4C, bot-
tom), suggesting that PfGAP50-GFP is reorganized after
merozoite release.
In an effort to determine the physical organization of
PfGAP50 within the IMC, we performed FRAP studies of
PfGAP50-GFP-labeled structures at different stages of para-
site development. In the trophozoite stage, application of an
intense laser pulse caused selective bleaching of PfGAP50-
GFP in a region of the ER (Fig. 5A). There was partial loss of
fluorescence from adjacent regions during the bleach pulse
and no recovery of the signal from other regions of the ER
over a period of 3 min. This indicates that at least part of the
PfGAP50-GFP is present in a state that shows restricted dif-
fusion. When the PfGAP50-GFP had redistributed to the api-
cal caps, there was no recovery of the signal after photobleach-
ing, indicating that PfGAP50-GFP from other caps cannot
diffuse into this compartment (Fig. 5B). When the PfGAP50-
GFP has redistributed around the periphery of the daughter
merozoites (Fig. 5C), loss of signal is restricted to the bleach
point and does not recover. This indicates that PfGAP50-GFP
is present in a protein complex that restricts lateral diffusion
within the membrane.
PfGAP50 is located in an apical IMC cap in developing
merozoites. The punctate PfGAP50-GFP-labeled structures
observed in developing merozoites are intriguing; however,
their small size limits the information that can be obtained
using conventional optical microscopy. 3D-SIM has recently
been developed as a method for imaging fluorescently labeled
samples with improved resolution (37). We used 3D-SIM to
image PfGAP50-GFP in parasites that are colabeled with
DAPI (Fig. 6).
The characteristic PfGAP50-GFP-labeled punctate struc-
tures are apparent in a parasite with 8 nuclei (Fig. 6A and C).
At higher resolution, it is evident that the PfGAP50-GFP-
containing caps are located at the apical ends of nascent mero-
zoites and form flat, ellipsoid structures, each with two unla-
beled “pores.” The average dimensions of these pores were
estimated to be 110  40 nm by 140  40 nm (n  18). The
nature of these structures and their organization relative to
the parasite nuclei can be best appreciated in a rotation of the
3D-SIM reconstruction presented in movie S1 in the supple-
mental material.
As the eight nuclei start to divide, the PfGAP50-GFP-la-
beled structures appear to be pulled apart, with the pores
opening to give a claw-like appearance (Fig. 6B and D). These
structures are organized in pairs, with the cavities facing each
other (Fig. 6D, arrow; for a rotation of the 3D-SIM recon-
struction, see movie S2 in the supplemental material). The
average length of the cavity is 230  40 nm, while the width in
its central region is 130  30 nm (n  18). These may represent
the apical caps of separating daughter cells in which the na-
scent IMC structures are pulled apart.
We performed EM on schizont stage parasites in an effort to
find an ultrastructural correlate of these doubly punctured
ellipsoids. In early-schizont stage parasites, apical prominences
are observed on the developing merozoites at either side of a
single nucleus (Fig. 6G and H). The apical prominence is
formed close to a mitotic spindle (Fig. 6H, m). The multiple
membranes and cytoskeletal components (microtubules) of the
nascent pellicle give this region an electron-dense appearance
(Fig. 6G and H, arrowheads). Later in development, separate
structures can be observed at the apical ends of the dividing
merozoites (Fig. 6I and J, arrowheads), which likely corre-
spond to the separating claw-like structures seen by 3D-SIM.
The “pores” in the PfGAP50-GFP-labeled cap presumably
correspond to the central region of the cytoskeletal annulus at
the apex of the cell. An electron tomogram was generated from
a section through a mature merozoite, and the tubulin rings are
observed in cross-section in a virtual section from the tomo-
gram (Fig. 6K, arrows). Four serial electron tomograms col-
lected through mature merozoites were rendered to generate a
model of a mature merozoite (Fig. 6L), with the apical rings
depicted in blue. These polar rings provide a structure through
which the rhoptry necks (indicated in burnt orange) are con-
nected to the parasite surface. The inner, middle, and outer
polar rings have diameters of approximately 120 nm, 180 nm,
and 240 nm. We interpret the 3D-SIM data to suggest that
PfGAP50 is recruited to the developing IMC and that the IMC
forms a membrane collar surrounding the apical pore.
As the schizont develops further, the PfGAP50-GFP ap-
pears to extend around the surface of the parasite (Fig. 6E and
F). The apical pores remain visible, but due to the extension of
the IMC around the periphery of the merozoite, which dilutes
the PfGAP50-GFP, they are less prominent. The change in
IMC organization is best appreciated by comparing the divid-
FIG. 5. Photobleach analysis of PfGAP50-GFP organization. The
panels are prebleach images with and without DIC overlay and post-
bleach images after application of a laser pulse at the positions indi-
cated by arrows. (A) A region of the ER in an early-trophozoite stage
parasite shows complete loss of fluorescence at the point of bleaching,
partial loss from a connected compartment, and little loss from an
adjacent compartment. There was no recovery after 3 min. (B) Appli-
cation of a laser pulse to PfGAP50-GFP in an apical cap in an early
schizont ablates fluorescence with no recovery from adjacent struc-
tures. (C) Spot bleaching of a region of PfGAP50-GFP in a region of
a mature merozoite results in complete loss of fluorescence at the
point of bleaching, with little loss from other regions of the same
merozoite or from adjacent merozoites. Bars  1 m.
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ing schizonts in movies S1 and S2 in the supplemental material
with the more mature schizonts in movies S3 and S4.
The C-terminal transmembrane domain of PfGAP50 is
needed for correct trafficking to the IMC. In T. gondii, the
transmembrane domain and the short C-terminal segment of
PfGAP50 are needed for correct assembly into the glideosome
complex (20). In an effort to determine whether the same
region of PfGAP50 is needed for correct trafficking and assem-
bly in P. falciparum, we generated transfectants expressing
GFP chimeras of two different PfGAP50 mutants (Fig. 7A)
and examined their intracellular locations.
Live-cell fluorescence microscopy of the PfGAP501-369-GFP
transfectants (lacking the C-terminal hydrophobic and cyto-
plasmic domains) (Fig. 7B) indicates that the chimera is in the
PV, with some protein being transferred to the digestive vac-
uole (Fig. 7B, middle). Colabeling of these cells with ER-
Tracker (Fig. 7B, bottom) confirms that the PfGAP501-369-
GFP fluorescence is outside the region of the ER. The data
suggest that the N-terminal signal peptide directs entry into the
secretory pathway and that, in the absence of amino acids 370
to 396, it follows the default trafficking pathway to the PV
(3). This confirms that the C-terminal transmembrane and
cytoplasmic domains are required for correct trafficking of
PfGAP50 to the IMC in P. falciparum.
Mature stage PfGAP501-369-GFP transfectants were re-
leased with streptolysin O and then ruptured, and the pellet
and supernatant fractions were subjected to Western analysis.
The transfectants express a protein of 61 kDa (Fig. 7C), which
is similar to the anticipated size of PfGAP501-369-GFP after
cleavage of the signal sequence, as well as a protein of 26 kDa,
which likely represents the protease-resistant core of GFP. The
full-length chimera is largely released into the supernatant
fraction, suggesting that it is a soluble protein. The cytoplasmic
protein PfGAPDH shows a similar solubility profile (Fig. 7C,
bottom).
The acid phosphatase homology domain of PfGAP50 is not
needed for correct trafficking to the IMC. PfGAP50 has a
central domain that exhibits 25% identity to different purple
acid phosphatases of plants and animals. To determine
whether this domain is needed for trafficking to the IMC, we
generated P. falciparum transfectants episomally expressing a
construct in which the acid phosphatase homology domain is
replaced by GFP (Fig. 7A). Live-cell fluorescence microscopy
reveals that the PfGAP50AP-GFP chimera has a fluores-
FIG. 6. The IMC forms around the apical pore of developing merozoites. 3D-SIM was performed on parasites expressing PfGAP50-GFP
(green) labeled with DAPI nuclear stain (depicted in red). (A and C) Schizont with eight nuclei, each with two associated PfGAP50-GFP-
containing ellipsoids. Each ellipsoid has two unlabeled “pores” (arrow). (B and D) A schizont with eight nuclei that are undergoing division
showing the PfGAP50-GFP-containing structures separating into claw-like structures (arrow). (E and F) Mature schizonts in which the PfGAP50-
GFP fluorescence is more evenly distributed around the periphery of the parasite. (G and H) Transmission EM (TEM) images of early schizonts
with electron-dense apical prominences with overlying membrane caps (arrowheads) forming in pairs on either side of a nucleus (n). The apical
caps are connected to the underlying electron-dense rhoptries (r) and form close to a mitotic spindle (m). (I) TEM image of a maturing schizont
showing invagination of the parasite plasma membrane around the daughter cells and separation of the apical caps (arrowheads). (J) TEM image
of a mature schizont showing electron-dense structures at the apical ends of closely apposed daughter cells (arrowheads). (K) Selected virtual
section (22 nm) through a tomogram showing a merozoite developing within a schizont. The electron-dense polar rings are indicated with black
arrows, and the IMC with a white arrow. A microneme (mc) is visible. (L) Rendered tomographic reconstructions of merozoites, generated from
serial sections through the schizont shown in panel K, showing the nucleus in yellow, rhoptries in burnt orange, dense granules in brown, the polar
rings in blue, the mitochondrion in green, and a cytostomal ring as a yellow circle. Rotations of the 3D projection in panels A, B, E, and F are
presented in movies S1 to S4 in the supplemental material. Bars  1 m (A to F, G, and J) and 500 nm (H, I, K, and L).
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cence pattern similar to that of full-length PfGAP50-GFP (Fig.
7D). This suggests that the phosphatase domain is not required
for correct trafficking of PfGAP50 to the IMC. Western anal-
ysis reveals a protein with an apparent molecular mass of 34
kDa (as expected) that is present in the pellet fraction (Fig.
7E), as for full-length PfGAP50-GFP. Unfortunately, these
domain-swapped transfectants grew poorly and were lost
within 2 to 3 weeks of the first appearance of fluorescent
parasites, and we were unable to obtain sufficient material to
confirm an interaction with other IMC proteins by immuno-
precipitation analyses. The data suggest that, while not essen-
tial for trafficking to the IMC, the acid phosphatase domain
may play an important role in PfGAP50 function.
DISCUSSION
The IMC of the merozoite is a cisternal structure that is
flattened against the plasma membrane of the developing
merozoite. It plays a critical role in anchoring the actin-myosin
motor that drives invasion. The IMC-associated glideosome
complex has been well studied in T. gondii and more recently
in Plasmodium; however, some aspects of its genesis and as-
sembly remain poorly understood.
We generated transfectants expressing an IMC protein,
PfGAP50, fused to GFP. We showed that in schizont stage
parasites, the chimera is membrane associated, is colocated
with the endogenous IMC-resident proteins PfGAP45 and
PfGAP50, and coprecipitates with PfGAP45 and MTIP. This
demonstrates that PfGAP50-GFP is correctly trafficked to the
IMC and is able to participate in a complex with endogenous
IMC proteins. The data are consistent with a previous report
for T. gondii GAP50-yellow fluorescent protein (YFP), which is
correctly targeted to the IMC of nascent daughter parasites
(20). An antiserum to T. gondii GAP45 (TgGAP45) was shown
to immunoprecipitate TgMyoA, TgGAP50, TgGAP45, and
TgMLC1, along with the TgGAP50-YFP fusion protein (20).
The fact that the C-terminal GFP fusion does not interfere
with the binding of PfGAP50 to PfGAP45 is at first surprising.
It is possible that the binding interface involves more than the
5 amino acids of the cytoplasmic domain of PfGAP50 or that
additional proteins are required for complex stability. Indeed,
it has been reported that PfGAP45 is both myristoylated
and palmitoylated (35). This may facilitate penetration of
PfGAP45 into the bilayer, providing a larger interaction area.
While the IMC and many of its components have been well
studied, little is known of its origin, its assembly at the apical
end of the daughter merozoite, or its redistribution during
merozoite development. It seems possible that PfGAP50 might
play a role in initiation of the IMC, given that PfGAP50 tran-
scription is initiated during the ring stage, peaking in the mid-
trophozoite stage (29). In contrast, other IMC components,
such as PfGAP45 and MyoA, are transcribed only in late tro-
phozoites.
Using tightly synchronized parasites and live-cell imaging,
we found that PfGAP50-GFP is associated with the ER of
late-ring to mid-trophozoite stage parasites. The GFP-tagged
PfGAP50 construct used in this study is expressed using the
PfCRT promoter rather than the endogenous PfGAP50 pro-
moter, and there may be some differences in the timing of
expression of the tagged and untagged proteins. However, we
confirmed that endogenous PfGAP50 is also colocated with
the ER-resident protein PfERC at this stage of development.
As the parasite matures, the PfGAP50-GFP-labeled structures
appear to loop out and then coalesce as punctate structures at
the parasite periphery. The data strongly suggest that the IMC
originates from the ER, although the mechanism by which this
occurs remains unclear. It is possible that initiation of the
expression of binding partners is the trigger that causes redis-
tribution of PfGAP50 to the IMC. Our data are supported by
data from T. gondii suggesting that the IMC is derived from the
ER (15), although in T. gondii, the organization is somewhat
different, as both the mother and daughter cells have an IMC.
Another study suggested that the IMC is derived from the
Golgi apparatus (25). While we cannot rule out participation
FIG. 7. The C terminus of PfGAP50 is required for correct traf-
ficking. (A) A truncation mutant of PfGAP50 lacking the C-terminal
domains (PfGAP501-369-GFP) and a mutant in which the acid phos-
phatase homology domain is replaced with GFP (PfGAP50AP-GFP)
were generated. (B and C) Location and solubility of episomally ex-
pressed PfGAP501-369-GFP. (B) Live confocal fluorescence images of
trophozoite and schizont stage parasites (top 2 panels) show mistraf-
ficking of PfGAP501-369-GFP to the PV outside the region labeled with
ER-Tracker (bottom). Bar  1 m. (C) Enriched PfGAP501-369-GFP
transfectants were treated with streptolysin O, followed by freeze-thaw
cycling. Supernatant (S) and pellet (P) fractions were subjected to
Western blotting, probed with antibodies recognizing GFP, and then
reprobed with anti-PfGAPDH. (D and E) Location and solubility of
episomally expressed PfGAP50AP-GFP. (D) Live-cell images show a
fluorescence pattern similar to that of the full-length PfGAP50-GFP.
Bar  1 m. (E) Late-stage parasites expressing PfGAP50AP-GFP
were harvested and lysed, and the Western blot of the pellet and
supernatant fractions was probed with mouse anti-GFP.
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of Golgi components in the generation of the IMC, PfGAP50
does not accumulate in that compartment.
By the time the schizont has developed to the 8-nucleus
stage (44 h postinvasion), PfGAP50-GFP is present in
doughnut-shaped puncta at the periphery of the parasite.
Doughnut-shaped IMC compartments have been observed
previously for parasites labeled with reagents recognizing
PfGAP45 (12, 24) or the novel IMC proteins PfGAPM1 (12)
and MAL13P1.130 (24). The punctate PfGAP50-GFP-labeled
structure that forms at the apical end of each developing mero-
zoite is intriguing, but its small size limits the information that
can be obtained using conventional light microscopy, which is
restricted to resolving features with dimensions about half the
wavelength of the illuminating photons. Recently, techniques
have been developed that circumvent the diffraction limit of
light (37). We used 3D-SIM to obtain more detailed informa-
tion about the architecture of the nascent IMC in PfGAP50-
GFP transfectants. We found that the IMC precursor is pres-
ent as a flattened ellipsoid that is punctured by two holes; this
structure separates into two apposing claw-shaped structures
as the nucleus starts to divide.
Ultrastructural studies of early-schizont stage parasites re-
veal an electron-dense protrusion at the apical end of each
developing merozoite. This apical prominence is the site of the
assembly of three tubulin-based annuli called the polar rings
that lie underneath the plasma membrane in this region of the
cell (4–6). In early-stage schizonts, the IMC membrane is ob-
served as a membrane cap in the region of the cytoskeletal
rings. It is possible that an interaction of PfGAP50 (or associ-
ated proteins) with the newly formed polar rings may initiate
the relocation of PfGAP50 from the ER to the apical promi-
nence. Our data are consistent with a previous EM study show-
ing that the merozoite IMC is formed close to endomitotic
spindles (5).
A previous ultrastructural study reported that the IMC cis-
terna extends radially from the apical rings, leaving a central
region that is free of cisternal membrane (5). Thus, the holes
in the PfGAP50-GFP-labeled nascent IMC presumably repre-
sent the region occupied by the polar rings (4, 6). As the
daughter merozoites form in the final stages of schizogony, the
PfGAP50-GFP profile extends further around the surface of
the nascent daughter cells; this is consistent with EM data
showing the extension of the IMC around the developing
merozoites. A model of the proposed reorganization of
PfGAP50 during IMC development is illustrated in Fig. S3 in
the supplemental material.
PfGAP50 and the related TgGAP50 exhibit 20 to 25% iden-
tity to purple acid phosphatases of various plants and animals
(20). As some of the amino acids that are considered critical
for enzyme activity are mutated in TgGAP50, it has been
assumed that apicomplexan GAP50 is an inactive homologue
of the acid phosphatase family (20). However, recently, a re-
combinantly expressed version of the acid phosphatase homol-
ogy domain of PfGAP50 has been generated and shown to
have activity as a small-molecule phosphomonoester hydrolase
(32). The recombinant enzyme exhibited a broad substrate
profile with optimal activity at pH 5 to 7.
Müller et al. (32) studied the intracellular location of
PfGAP50. In contrast to our work, these authors concluded
that PfGAP50 is trafficked to the parasite plasma membrane
and subsequently engulfed in the digestive vacuole. Their study
involved the generation of transfectants expressing a chimera
comprising the first 99 amino acids of PfGAP50 linked to GFP.
This chimera enters the secretory pathway and is trafficked to
the PV and, in part, to the digestive vacuole. This is similar to
the pattern we observed for the PfGAP50 mutant lacking the
C-terminal hydrophobic domain. Similarly a YFP chimera of
TgGAP50 lacking the C-terminal 6 amino acids was not incor-
porated into the glideosome complex (20). We suggest that
trafficking of PfGAP50 to the PV and digestive vacuole occurs
only in the absence of the C-terminal membrane anchor, which
we have shown is essential for correct trafficking and mem-
brane association of PfGAP50. Müller et al. (32) also
generated transfectants expressing GFP linked to full-length
PfGAP50 and reported that the fluorescence was present in
the ER in trophozoite stage parasites. This is in agreement
with our data; however, they did not investigate the location of
the full-length chimera in schizont stage parasites. Our data
suggest that correctly trafficked full-length protein is initially
resident in the ER and then relocates to the inner membrane
complex of nascent daughter merozoites.
Müller et al. (32) suggested that PfGAP50 might play a role
in the dephosphorylation of host nutrients to facilitate trans-
port into the parasite. While this seems less likely if PfGAP50
is located in the ER/IMC compartments, alternative roles for
the protein in early-stage parasites cannot be discounted. It is
of interest to consider whether the phosphatase activity of
PfGAP50 might play a role in the assembly of the glideosome
complex. For example, phosphorylation of GAP45 has been
shown to control the assembly of the T. gondii motor complex
(21). It is important to note, however, that the phosphatase
domain of PfGAP50 is predicted to face the lumen of the
ER/IMC, while PfGAP45 is located in the parasite cytoplasm.
Indeed, our finding that the truncated PfGAP501-369-GFP is
released as a soluble protein into the PV supports the pre-
dicted orientation with the phosphatase domain facing the ER
lumen. It remains possible, nonetheless, that PfGAP50 de-
phosphorylates structural components within the IMC lumen.
In this work, we found that when the acid phosphatase
domain of PfGAP50 was replaced by GFP, the protein still
appeared to be correctly trafficked; however, these parasites
rapidly lost fluorescence, and the level of protein expression
was very low (as assessed by Western analysis). This suggests
that expression of PfGAP50 with a defective phosphatase do-
main (even in the presence of endogenous PfGAP50) may be
deleterious to parasite growth. Attempts to generate transfec-
tants in which PfGAP50AP-GFP replaced the endogenous
gene were not successful (unpublished data), again suggesting
that the acid phosphatase domain may perform some impor-
tant enzymatic activity or structural role. A similar growth
disadvantage was observed in T. gondii when the phosphatase
domain was replaced with the human purple phosphatase do-
main (20).
In conclusion, our data indicate that PfGAP50 plays an
important role in the initial stages of the formation of the IMC
of P. falciparum. We speculate that recruitment of a PfGAP50-
containing cisternal compartment from the ER represents an
early event in IMC formation. Further development of the
IMC likely involves the expression and assembly of additional
glideosome complex proteins, and we confirmed that PfGAP50
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is attached to PfGAP45 and MTIP, thereby linking the IMC to
the glideosome complex. Interactions with a subpellicular ra-
dial network of microtubules may facilitate extension of the
IMC underneath the parasite plasma membrane. Our data
show that the C-terminal membrane anchor of PfGAP50 is
critical for correct trafficking and suggest that the phosphatase
homology domain may also have an important function. Ad-
ditional work may reveal a means of inhibiting PfGAP50 func-
tion, which would arrest merozoite development and stop par-
asite invasion.
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